Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2 - PubMed (original) (raw)
. 1996 Dec 27;87(7):1181-90.
doi: 10.1016/s0092-8674(00)81814-0.
L M Boon, K L Carraway 3rd, J T Calvert, A J Diamonti, B Goumnerov, K A Pasyk, D A Marchuk, M L Warman, L C Cantley, J B Mulliken, B R Olsen
Affiliations
- PMID: 8980225
- DOI: 10.1016/s0092-8674(00)81814-0
Free article
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
M Vikkula et al. Cell. 1996.
Free article
Abstract
Venous malformations (VMs), the most common errors of vascular morphogenesis in humans, are composed of dilated, serpiginous channels. The walls of the channels have a variable thickness of smooth muscle; some mural regions lack smooth muscle altogether. A missense mutation resulting in an arginine-to-tryptophan substitution at position 849 in the kinase domain of the receptor tyrosine kinase TIE2 segregates with dominantly inherited VM in two unrelated families. Using proteins expressed in insect cells, we demonstrate that the mutation results in increased activity of TIE2. We conclude that an activating mutation in TIE2 causes inherited VMs in the two families and that the TIE2 signaling pathway is critical for endothelial cell-smooth muscle cell communication in venous morphogenesis.
Comment in
- Blood vessel formation: what is its molecular basis?
Folkman J, D'Amore PA. Folkman J, et al. Cell. 1996 Dec 27;87(7):1153-5. doi: 10.1016/s0092-8674(00)81810-3. Cell. 1996. PMID: 8980221 Review. No abstract available.
Similar articles
- Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.
Morris PN, Dunmore BJ, Tadros A, Marchuk DA, Darland DC, D'Amore PA, Brindle NP. Morris PN, et al. J Mol Med (Berl). 2005 Jan;83(1):58-63. doi: 10.1007/s00109-004-0601-9. Epub 2004 Oct 29. J Mol Med (Berl). 2005. PMID: 15526080 - Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
Du Z, Zheng J, Zhang Z, Wang Y. Du Z, et al. J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):740-748. doi: 10.1016/j.jvsv.2017.05.001. Epub 2017 May 16. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818232 Review. - Mutant Tie2 causing venous malformation signals through Shc.
Morris PN, Dunmore BJ, Brindle NP. Morris PN, et al. Biochem Biophys Res Commun. 2006 Jul 21;346(1):335-8. doi: 10.1016/j.bbrc.2006.05.128. Epub 2006 May 30. Biochem Biophys Res Commun. 2006. PMID: 16756945 - Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.
Hu HT, Huang YH, Chang YA, Lee CK, Jiang MJ, Wu LW. Hu HT, et al. J Invest Dermatol. 2008 Sep;128(9):2325-33. doi: 10.1038/jid.2008.89. Epub 2008 Apr 10. J Invest Dermatol. 2008. PMID: 18401423 - Blood vessel formation: what is its molecular basis?
Folkman J, D'Amore PA. Folkman J, et al. Cell. 1996 Dec 27;87(7):1153-5. doi: 10.1016/s0092-8674(00)81810-3. Cell. 1996. PMID: 8980221 Review. No abstract available.
Cited by
- Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms.
Reis LM, Seese SE, Costakos D, Semina EV. Reis LM, et al. Prog Retin Eye Res. 2024 Sep;102:101288. doi: 10.1016/j.preteyeres.2024.101288. Epub 2024 Aug 2. Prog Retin Eye Res. 2024. PMID: 39097141 Review. - Shear stress and pathophysiological PI3K involvement in vascular malformations.
Abdelilah-Seyfried S, Ola R. Abdelilah-Seyfried S, et al. J Clin Invest. 2024 May 15;134(10):e172843. doi: 10.1172/JCI172843. J Clin Invest. 2024. PMID: 38747293 Free PMC article. Review. - NRASQ61R mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model.
Pastura P, McDaniel CG, Alharbi S, Fox D, Coleman B, Malik P, Adams DM, Le Cras TD. Pastura P, et al. Pediatr Blood Cancer. 2024 Jul;71(7):e31032. doi: 10.1002/pbc.31032. Epub 2024 May 6. Pediatr Blood Cancer. 2024. PMID: 38711167 - Association Between the miR-100 rs1834306 A>G Polymorphism and Susceptibility to Venous Malformation.
Wu G, Lin X, Jiang H, Liu Z. Wu G, et al. Int J Gen Med. 2024 Feb 9;17:509-515. doi: 10.2147/IJGM.S441542. eCollection 2024. Int J Gen Med. 2024. PMID: 38356685 Free PMC article. - Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations.
Seront E, Van Damme A, Legrand C, Bisdorff-Bresson A, Orcel P, Funck-Brentano T, Sevestre MA, Dompmartin A, Quere I, Brouillard P, Revencu N, De Bortoli M, Hammer F, Clapuyt P, Dumitriu D, Vikkula M, Boon LM. Seront E, et al. JCI Insight. 2023 Nov 8;8(21):e173095. doi: 10.1172/jci.insight.173095. JCI Insight. 2023. PMID: 37937645 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous